- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03328182
Assessment of an Oral Endotracheal Subglottic Tube Holder
July 2, 2019 updated by: Hollister Incorporated
Assessment of AnchorFast Guard Subglottic ET (Endotracheal) Tube
This study is designed to assess the acceptability and usability of a new Endotracheal Tube (ET) holding device for an orally intubated patient.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a multiple site prospective assessment of the study product in ICU settings.
The study is comprised of each intubated subject wearing one study product until the device either needs to be changed or is no longer required by the subject.
The study product is designed to hold a standard or subglottic ET tube and help reduce the potential for occlusion (blockage) of the tube.
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Fresno, California, United States, 93701
- Community Regional Medical Center
-
-
Oregon
-
Gresham, Oregon, United States, 97030
- Legacy Mount Hood Medical Center
-
Portland, Oregon, United States, 97210
- Legacy Good Samaritan Medical Center
-
Portland, Oregon, United States, 97227
- Legacy Emanuel Hospital & Health Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
INCLUSION CRITERIA
- Is 18 years of age or older and require oral tracheal intubation with subglottic ET tube size 6.0-8.0mm
- Requires the use of a bite block per the hospital's standard of care
- Has intact skin on and around application site, including cheeks and lips
- Oral cavity is free of open sores, ulcers, wounds, and lesions
- Subject or Legal Authorized representative (LAR) able to provide informed consent for the study
- Is qualified to participate in the opinion of the Investigator, or designee
EXCLUSION CRITERIA
- Has actual or perceived loose teeth, is without teeth, or is unable to wear upper dentures
- Has facial hair that interferes with the adhesion of the skin barrier pads
- Has a clinically significant skin disease or condition, or damaged skin on the application site, such as psoriasis, eczema, atopic dermatitis, active cancer, sores, sunburns, scars, moles
- Has a medical condition, surgery or a procedure that prevents the proper application of the device, including placement of the neck strap.
- Has a known or stated allergy to adhesives
- Currently is participating in any clinical study which may affect the performance of the device
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: New oral endotracheal tube holder
Single Study Product Arm
|
The single arm study product is designed to hold a standard or subglottic ET tube.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall Acceptability With Study Product
Time Frame: At product removal (maximum 29 days of patient wearing product)
|
The overall acceptability relating to general experience with the study product during use will be rated with a 5-point Likert scale ranging from 1=Very Unacceptable to 5=Very Acceptable
|
At product removal (maximum 29 days of patient wearing product)
|
Usability of Study Product
Time Frame: At application and product removal (maximum 29 days of patient wearing product)
|
The usability of the study product at application and at removal.
|
At application and product removal (maximum 29 days of patient wearing product)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Laura Vander Werff, MD, Legacy Mount Hood Medical Center
- Principal Investigator: Brian Young, MD, 1. Legacy Emanuel Hospital & Health Center 2. Legacy Good Samaritan Medical Center
- Principal Investigator: Arash Afshinnik, MD, Community Regional Medical Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Buckley JC, Brown AP, Shin JS, Rogers KM, Hoftman NN. A Comparison of the Haider Tube-Guard(R) Endotracheal Tube Holder Versus Adhesive Tape to Determine if This Novel Device Can Reduce Endotracheal Tube Movement and Prevent Unplanned Extubation. Anesth Analg. 2016 May;122(5):1439-43. doi: 10.1213/ANE.0000000000001222.
- Mohammed, H & Hassan, M. (2015). Endotracheal tube securements: Effectiveness of three techniques among orally intubated patients. Egyptian Journal of Chest Diseases and Tuberculosis 64:183-196
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 23, 2017
Primary Completion (Actual)
June 8, 2018
Study Completion (Actual)
June 15, 2018
Study Registration Dates
First Submitted
October 16, 2017
First Submitted That Met QC Criteria
October 27, 2017
First Posted (Actual)
November 1, 2017
Study Record Updates
Last Update Posted (Actual)
July 5, 2019
Last Update Submitted That Met QC Criteria
July 2, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 5855-I
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intubation
-
Spanish Network for Research in Infectious DiseasesCompletedIntubation | Intubation Complication | Intubation; Difficult or FailedSpain
-
University Hospital, Clermont-FerrandSociété Française d'Anesthésie-Réanimation (SFAR)Not yet recruitingEndotracheal Intubation | Intubation Complication | Intubation; Difficult or Failed
-
Children's Hospital of PhiladelphiaAgency for Healthcare Research and Quality (AHRQ)RecruitingIntubation Complication | Intubation; Difficult | Failed or Difficult Intubation, SequelaUnited States, Canada, Japan, Italy, New Zealand, Singapore, Australia, Austria, Germany, India, United Kingdom
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedIntubation, Nasotracheal IntubationTaiwan
-
Emory UniversityTerminatedAirway Morbidity | Intubation Complication | Anesthesia Intubation Complication | Tracheal Intubation Morbidity | Failed or Difficult Intubation, SequelaUnited States
-
Catharina Ziekenhuis EindhovenCompletedAnesthesia Intubation Complication | Intubation; Difficult | Failed or Difficult Intubation | Failed or Difficult Intubation, Initial EncounterNetherlands
-
Children's Hospital of PhiladelphiaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedIntubation Complication | Intubation;Difficult | Failed or Difficult Intubation, SequelaUnited States, Canada, Singapore
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedIntubation Complication | Intubation, DifficultTaiwan
-
Huazhong University of Science and TechnologyCompletedIntubation Complication | Intubation; DifficultChina
-
University at BuffaloTerminatedIntubation Complication | Intubation;DifficultUnited States
Clinical Trials on New oral endotracheal tube holder
-
Hollister IncorporatedTerminatedRespiratory Failure | Ventilatory Depression | Respiratory DepressionUnited States
-
Cumhuriyet UniversityRecruitingInfection | Intensive Care | Nurses Role | Patient CareTurkey
-
Karaman Training and Research HospitalCompleted
-
University of LisbonCompleted
-
University Hospital, MontpellierCompletedCritically Ill | Intubation ComplicationFrance
-
Kyungpook National University HospitalCompletedEndotracheal Tube | Cuff PressureKorea, Republic of
-
Rambam Health Care CampusCompletedEndotracheal IntubationIsrael
-
Hallym University Kangnam Sacred Heart HospitalCompletedHeart ArrestKorea, Republic of
-
Kyungpook National University HospitalCompletedCuff PressureKorea, Republic of
-
Marmara University Pendik Training and Research...Completed